Press Releases


APhA and NASPA release 2021 National State-based Pharmacy Workplace Survey report

WASHINGTON, DC—The American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) have released the final report of the 2021 National State-based Pharmacy Workplace Survey.

APhA appreciates CMS’ elimination of retroactive DIR fees

Though more actions are needed to address PBMs’ harmful business practices

WASHINGTON, D.C.—CMS has issued a final rule eliminating Part D plans’ and PBMs’ use of retroactive direct and indirect remuneration (DIR) fees beginning on January 1, 2024 (contract year 2024). The American Pharmacists Association (APhA) and many of its members submitted comments to CMS on the proposal. APhA appreciates CMS’ efforts to end the uncertainty and lack of drug cost transparency at the pharmacy caused by retroactive DIR fees.

APhA welcomes their 2022–2023 Executive Residency Program class

WASHINGTON, DC – The American Pharmacists Association announced today that its 2022–2023 class of executive residents has been selected.

APhA addresses AMA’s inaccurate description of H.R. 7213 and viewpoints of most physicians working alongside pharmacists

WASHINGTON, DC – The American Pharmacists Association released the following statement in response to an April 12, 2022, letter from the American Medical Association (AMA) to Representatives Kind and McKinley regarding H.R. 7213, the “Equitable Community Access to Pharmacist Services Act.”  

Actions of the 2022 APhA House of Delegates

San Antonio, TX, March 18 – 21, 2022

WASHINGTON, D.C.—The American Pharmacists Association (APhA) released today official policies and guidance for the House of Delegates adopted by the March 2022 APhA House of Delegates in San Antonio, TX,  March 18 – 21, 2022. These statements are now official APhA policy.